3Anand A. Human parovirus infection in pregnancy and hydrops fetalis.N Engl J Med, 1987:316:183.
4Rodis JF, Management and outcomes of pregnancies complicated by human B19 parovirus infection:a prospective study Am J Obstet Gynecol, 1990:163:1168.
5Fisher DA.Fetal thyroid function diagnosis and management of fetal thyroid disorders Clin Obster Gynecol,1997,40(1):16.
6Wolff F. Phenotal diagnosis and therapy of fetal heart rate anomalies with a contribution on the placental transfer of verapamil. J Perinat Med, 1980: 8: 203.
7Rubin PC. Beta - blockers in pregnancy. N Engl J Med,1981:305:1323.
8Abuhamad AZ, Fisher DA, Warsot SL, Antenatal diagnosis and treatment of fetal goitrous hypothyroidism: case report and review of the literature. Ultrasound Obstet Gynecol,1995:6:368.
9Buchmiller TL, Kim CS, Chopourian H, et al. Transamniotic fetal feeding. Enhancement of growth in a rabbit model of intrauterine growth retardation. Surgery, 1994:116:36.
10Harding JE.Owens JA,Robinson JS Should we try to supplement the growth retarded fetus?A cautionary tale.Br J Obstet Gynaeco,192:99:707.
8[4]Yeomams ER,Hauth JC,Gilstrap Lc,etal.Umbilical cord PH pco2 and bicar.
9[2]Tongong T.Sonographic diagnosis of intrauterine growth restriction by fetal transverse cerebellar diameter(TCD)/abdominal circumference(AC)ratio.Int J Gynaecol Obstet,1999,66:1-5.
10Tongsong T. Sonographic diagnosis of intrauterine growth restriction by fetal transverse cerebellar diameter (TCD) /abdominal circumference (AC) ratio [J]. Int J Gynaeccol Obstet, 1999, 66:1.
